We are live on ! Find out more
HS

HighVista Strategies Portfolio holdings

AUM $362M
1-Year Est. Return 230.96%
This Fund
S&P 500
This Quarter Est. Return
+18.87%
1 Year Est. Return
+230.96%
3 Year Est. Return
+518.4%
5 Year Est. Return
+644.94%
10 Year Est. Return
+2,223.31%
AUM
$137M
AUM Growth
+$16.5M
Cap. Flow
+$772K
Cap. Flow %
0.56%
Top 10 Hldgs %
68.51%
Holding
147
New
47
Increased
29
Reduced
15
Closed
34

Top Buys

Rank Stock Value
1
DLPH
Delphi Technologies PLC Ordinary Shares
DLPH
+$3.12M
2
LVGO
Livongo Health, Inc. Common Stock
LVGO
+$3.04M
3
MXIM
Maxim Integrated Products
MXIM
+$2.88M
4
GRUB
Just Eat Takeaway.com N.V. American Depositary Shares
GRUB
+$2.01M
5
STRO icon
Sutro Biopharma
STRO
+$611K

Top Sells

Rank Stock Value
1
TECD
Tech Data Corp
TECD
+$7.91M
2
CZR
Caesars Entertainment Corporation
CZR
+$4.15M
3
LOGM
LogMein, Inc.
LOGM
+$2.89M
4
PRNB
Principia Biopharma Inc. Common Stock
PRNB
+$548K
5
EIDX
Eidos Therapeutics, Inc. Common Stock
EIDX
+$505K

Sector Composition

Rank Sector Weight
1 Technology 36.76%
2 Healthcare 21.07%
3 Financials 13.05%
4 Consumer Discretionary 10.17%
5 Communication Services 3.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TEO icon
101
Telecom Argentina
TEO
$5.81B
$71K 0.05%
+10,800
New +$87.4K
ARAY icon
102
Accuray
ARAY
$34.6M
$68K 0.05%
28,300
– –
ATEN icon
103
A10 Networks
ATEN
$1.97B
$68K 0.05%
10,700
– –
RLGT icon
104
Radiant Logistics
RLGT
$391M
$66K 0.05%
12,900
– –
DVAX
105
DELISTED
Dynavax Technologies
DVAX
$64K 0.05%
+14,700
New +$105K
WSR
106
DELISTED
Whitestone REIT
WSR
$62K 0.05%
10,300
– –
CDTX
107
DELISTED
Cidara Therapeutics
CDTX
$60K 0.04%
+1,060
New +$74.9K
VKTX icon
108
Viking Therapeutics
VKTX
$3.94B
$59K 0.04%
10,100
– –
HROW icon
109
Harrow
HROW
$1.47B
$58K 0.04%
10,300
– –
OSG
110
DELISTED
Overseas Shipholding Group Inc.
OSG
$56K 0.04%
26,400
– –
SBBP
111
DELISTED
Strongbridge Biopharma plc.
SBBP
$49K 0.04%
+23,100
New +$77.9K
EPM icon
112
Evolution Petroleum
EPM
$135M
$44K 0.03%
19,800
– –
DHX icon
113
DHI Group
DHX
$166M
$34K 0.02%
15,100
– –
AKBA icon
114
Akebia Therapeutics
AKBA
$240M
– –
-11,800
Closed -$160K
ALEC icon
115
Alector
ALEC
$233M
– –
-17,352
Closed -$424K
ALLK
116
DELISTED
Allakos
ALLK
– –
-5,635
Closed -$405K
ALNY icon
117
Alnylam Pharmaceuticals
ALNY
$29.6B
– –
-2,805
Closed -$415K
ARVN icon
118
Arvinas
ARVN
$588M
– –
-14,467
Closed -$485K
BMRN icon
119
BioMarin Pharmaceuticals
BMRN
$13.5B
– –
-3,384
Closed -$417K
BPMC
120
DELISTED
Blueprint Medicines
BPMC
– –
-5,396
Closed -$421K
CDXS icon
121
Codexis
CDXS
$159M
– –
-38,009
Closed -$433K
CPRX
122
DELISTED
Catalyst Pharmaceutical
CPRX
– –
-15,800
Closed -$73K
KALA icon
123
KALA BIO
KALA
$16.3M
– –
-16
Closed -$420K
MNKD icon
124
MannKind Corp
MNKD
$1.23B
– –
-48,600
Closed -$85K
MNOV icon
125
MediciNova
MNOV
$65M
– –
-11,700
Closed -$63K
2 3 4
5
6

Similar funds

SIAG
Safeguard Investment Advisory Group Corona, California $362M AUM 20.96% 1-Year Est. Return
MS
Millington Securities Red Bank, New Jersey $362M AUM
WTFG
Wood Tarver Financial Group Boise, Idaho $362M AUM 14.75% 1-Year Est. Return
A6
Anchor @ 65 Singapore $362M AUM 20.02% 1-Year Est. Return
PI
Pennant Investors Summit, New Jersey $361M AUM 134.26% 1-Year Est. Return
ACM
Anfield Capital Management Irvine, California $363M AUM 24.08% 1-Year Est. Return
PPG
Peak Planning Group Centennial, Colorado $361M AUM 22.01% 1-Year Est. Return
PWC
PYA Waltman Capital Knoxville, Tennessee $361M AUM 9.49% 1-Year Est. Return

HighVista Strategies's Q3 2020 Portfolio in Review

As of Q3 2020, HighVista Strategies held 147 positions worth $137M, up 14% from $121M the previous quarter. Its ten largest holdings account for 69% of the portfolio.

HighVista Strategies's Q3 2020 filing shows 47 new, 29 increased, 15 reduced and 34 closed positions. Its largest new stake was Delphi Technologies PLC Ordinary Shares: 189,132 shares worth $3.16M. The largest sale was Tech Data Corp, an estimated $7.91M.

By sector, the portfolio is most concentrated in Technology at 37% of assets, down from 43% a quarter earlier, followed by Healthcare and Financials.

  • HighVista Strategies's largest Q3 2020 buy was Delphi Technologies PLC Ordinary Shares: 189,132 shares worth $3.16M.
  • HighVista Strategies added most to Xenon Pharmaceuticals in Q3 2020, an estimated $274K increase.
  • HighVista Strategies's biggest Q3 2020 reduction was Kadmon Holdings, Inc., cutting an estimated $256K.
  • HighVista Strategies fully exited Tech Data Corp in Q3 2020, selling an estimated $7.91M.
  • HighVista Strategies's ten largest holdings make up 69% of its $137M portfolio in Q3 2020.
  • HighVista Strategies opened 47 new positions and closed 34 in Q3 2020.
  • HighVista Strategies's portfolio value rose 14% quarter-over-quarter to $137M.

Based on HighVista Strategies's 13F filing for Q3 2020, filed 16 Nov 2020.